Is Presbyopia Finally Taking Center Stage?
Presbyopia is the eye condition that will impact 100% of patients at some point. It has long been said that a solution for presbyopia is the “holy grail” of eye care. While there is not yet a cure for presbyopia, there are more tools than ever before to help patients have functional near and intermediate vision while maintaining distance vision. Recently, George O. Waring IV, MD, FACS, moderated a discussion with Steven J. Dell, MD; Rex Hamilton, MD, MS, FACS; and Cathleen M. McCabe, MD, on the profound need for eye care providers to provide more presbyopia solutions to their patients and how they are doing that.
Explore More Articles
VIDEO: New laser offers further improvement to laser scleral microporation
BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, AnnMarie Hipsley, DPT, PhD, and George O. Waring IV, MD, FACS, discuss the latest advances in laser scleral microporation.Hipsley said that the GenII VisioLite laser for laser scleral microporation (LSM) is on the pathway to commercialization and may be available by the end of the year.
read moreIs Presbyopia Finally Taking Center Stage?
Presbyopia is the eye condition that will impact 100% of patients at some point. It has long been said that a solution for presbyopia is the “holy grail” of eye care. While there is not yet a cure for presbyopia, there are more tools than ever before to help patients have functional near and intermediate …
read moreDynamic range of focus recovery in presbyopes after laser scleral microporation
While considered by many to be a “normal process of aging,” the loss of the dynamic focusing function of the eye, presbyopia, is a progressive disease of ocular aging. Presbyopia affects approximately 1.8 billion people globally.1 Estimated global annual productivity losses are approximately 0.037% of the global gross domesticproduct in presbyopic adults less than 65 years …
read more